The CY 2027 Final Rule Is Out. What Changed, What's New, and Why It Matters If You Sell to Health Plans.

Key Takeaways

• Health equity mandates eliminated, shrinking compliance vendor market
• 11 Stars measures cut; depression screening added as new metric
• Supplemental benefit cards require real‑time POS verification this year
• SSBCI eligibility criteria must be publicly posted by plans
• Agent/broker restrictions lifted, expanding enrollment technology demand

Pulse Analysis

The CMS final rule marks a decisive shift toward deregulation while sharpening enforcement on core quality metrics. By scrapping the Health Equity Index reward and three related requirements, CMS removes a major compliance driver that had justified a whole category of analytics and SDOH solutions. Vendors that previously leaned on mandatory equity reporting now need to demonstrate clear financial returns—cost avoidance, readmission reductions, and risk‑adjustment gains—to persuade plan executives. This pivot opens opportunities for firms that can quantify ROI and align with plans’ strategic goals rather than relying on regulatory mandates.

STAR ratings undergo a substantial overhaul: eleven administrative measures are stripped away, concentrating the scoring system on clinical outcomes and member experience. The addition of a Depression Screening and Follow‑Up measure gives behavioral‑health vendors a concrete hook, while the increased weight of CAHPS and HOS surveys raises the stakes for member‑experience platforms. The net effect is an estimated $18.6 billion impact on the Medicare Trust Fund through 2036, underscoring the financial importance of meeting the new quality standards. Companies that can link their solutions to both STAR performance and risk‑adjustment revenue will stand out in upcoming bid cycles.

Operationally, the rule introduces two surprise supplemental‑benefit provisions. Plans must publicly post SSBCI eligibility criteria and adopt real‑time POS verification for debit‑card purchases, demanding upgraded technology stacks from benefits‑administration vendors. Simultaneously, the removal of the 48‑hour Scope‑of‑Appointment waiting period and other broker constraints expands the enrollment‑technology market, giving agents greater flexibility to market plans with robust supplemental offerings. Vendors that can provide transparent compliance dashboards, real‑time eligibility engines, and agile enrollment tools are poised to capture the reallocated budget as plans redirect savings from rolled‑back equity programs toward these higher‑priority areas.